Chris Whitehouse is Director of Health and MedTech Policy at Whitehouse Communications, with extensive experience advising companies and trade associations across Westminster, Whitehall and Brussels. He chairs organisations representing the NHS’s private sector partners and is a leading columnist on health and MedTech policy for MedTech Insights Magazine. He has worked closely with the DHSC’s Medical Technology and Innovation Unit on developing a new assessment methodology for MedTech device procurement, and is a passionate advocate of value-based healthcare.
Matchmaking Information
Attending
Insights Stage
Beyond Price: How Value-Based Procurement is Reshaping NHS MedTech
This session explores the principles underpinning value-based procurement in MedTech, the evidence supporting its adoption, and the NHS’s plans for rolling it out across England. Chaired by Chris Whitehouse, it brings together senior voices from the Department of Health and Social Care, industry and clinical practice to examine a new assessment methodology for MedTech device procurement — developed in collaboration with DHSC’s Medical Technology and Innovation Unit. Speakers will explore the benefits the new approach can deliver, the challenges that remain, and what it means in practice for suppliers, clinicians and commissioners.
